GUNZ vs. CNCR ETF Comparison
Comparison of Tuttle Capital Self Defense Index ETF (GUNZ) to Loncar Cancer Immunotherapy ETF (CNCR)
GUNZ
Tuttle Capital Self Defense Index ETF
GUNZ Description
GUNZ is the first ETF that seeks to offer a values-driven focus on US self-defense products and services. From a starting universe of US-listed stocks, the fund considers companies involved in the manufacture, service, supply, and distribution of personal and law enforcement defense equipment and protection services. To qualify, a company should be engaged in any of the following categories: (1) the manufacture, wholesale, or retail of firearms, ammunition, gun parts, or other personal and law enforcement defense equipment or (2) the manufacture of home security equipment or development of video surveillance and emergency management systems. The company selects stocks that meet market-cap and liquidity requirements. The portfolio is then weighted equally. The index is rebalanced and reconstituted on the last business day of every quarter.
Grade (RS Rating)
Last Trade
$25.37
Average Daily Volume
243
18
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.74
Average Daily Volume
3,771
67
Performance
| Period | GUNZ | CNCR |
|---|---|---|
| 30 Days | -4.29% | 0.07% |
| 60 Days | -2.25% | |
| 90 Days | 3.58% | |
| 12 Months | 45.65% |
0 Overlapping Holdings
| Symbol | Grade | Weight in GUNZ | Weight in CNCR | Overlap |
|---|
GUNZ Underweight 67 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| BMEA | D | -1.91% | |
| TYRA | F | -1.89% | |
| ELVN | B | -1.75% | |
| HCM | C | -1.74% | |
| ACLX | B | -1.55% | |
| REPL | B | -1.55% | |
| MGNX | C | -1.55% | |
| YMAB | A | -1.54% | |
| AURA | B | -1.54% | |
| AUTL | D | -1.51% | |
| KPTI | C | -1.5% | |
| RVMD | A | -1.47% | |
| BMY | A | -1.43% | |
| DAWN | A | -1.42% | |
| TSVT | D | -1.42% | |
| ARVN | C | -1.42% | |
| MRUS | C | -1.41% | |
| MRSN | D | -1.41% | |
| JANX | A | -1.4% | |
| EXEL | A | -1.39% | |
| RPTX | C | -1.39% | |
| RCUS | F | -1.38% | |
| IGMS | B | -1.37% | |
| BCYC | D | -1.37% | |
| SNDX | F | -1.37% | |
| KYMR | C | -1.36% | |
| XNCR | A | -1.35% | |
| IOVA | B | -1.35% | |
| ALLO | D | -1.35% | |
| GNLX | C | -1.32% | |
| BPMC | C | -1.32% | |
| ACRV | B | -1.32% | |
| IMCR | F | -1.31% | |
| NRIX | B | -1.31% | |
| ACET | F | -1.3% | |
| CRBU | D | -1.28% | |
| STRO | D | -1.28% | |
| RXRX | F | -1.28% | |
| PGEN | F | -1.27% | |
| GERN | C | -1.26% | |
| LYEL | F | -1.25% | |
| CGEM | F | -1.24% | |
| SDGR | F | -1.23% | |
| RAPT | D | -1.23% | |
| ERAS | C | -1.23% | |
| MRK | F | -1.22% | |
| ZNTL | D | -1.22% | |
| BNTX | B | -1.21% | |
| IPHA | D | -1.18% | |
| GLUE | A | -1.17% | |
| LEGN | F | -1.16% | |
| GMAB | F | -1.15% | |
| NUVL | D | -1.13% | |
| FHTX | C | -1.11% | |
| REGN | F | -1.1% | |
| KURA | F | -1.1% | |
| SWTX | D | -1.09% | |
| IDYA | F | -1.08% | |
| RLAY | F | -1.05% | |
| FATE | F | -1.03% | |
| IMRX | D | -1.02% | |
| NUVB | F | -1.02% | |
| ITOS | F | -0.99% | |
| IMTX | F | -0.99% | |
| VOR | D | -0.94% | |
| SMMT | C | -0.92% | |
| PRLD | F | -0.85% |
GUNZ: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
